Aim:

To evaluate whether the newly-synthesized positron emission tomography (PET) tracer, [¹⁸F]2-(4'-(methylamino)phenyl)-6-fluoroethoxy- benzothiazole ([¹⁸F]O-FEt-PIB), could bind to -amyloid aggregates in a rat model of Alzheimer's disease (AD) using micro-PET.

Method:

[¹⁸F]O-FEt-PIB was synthesized and purified by radio HPLC. PET imaging was performed with a R4 rodent model scanner in 3 model and 3 control rats. Dynamic PET scans were performed for 40 min in each rat following an injection of approximately 37 MBq of [¹⁸F]O-FEt-PIB. Static scans were also performed for 15 min in each rat. PET data were reconstructed by a maximum posteriori probability algorithm. On the coronal PET images, regions of interest were respectively placed on the cortex, hemicerebrum [including the hippocampus and thalamus (HT)], and were guided by a 3-D digital map of the rat brain or the brain images of [¹⁸F]2-Deoxy-2-fluoro-D-glucose ([¹⁸F]FDG) in normal rats. Time-activity curves (TAC) were obtained for the cerebrum and cerebellum. The activity difference value (ADV) between 2 hemicerebrums was also calculated.

Results:

The TAC for [¹⁸F]O-FEt-PIB in the cerebrum or cerebellum peaked early (at approximately 2 min), but washed out a little slowly. In the dynamic and static micro-PET images, increased radioactivity was found in the area of the right HT in the model rats where infused with -amyloid (1–40). No distinct difference of radioactivity was found between the right and left HT areas in the control rats. The ADV(_HT) was approximately 14.6% in the AD model rats and approximately 4 times greater than that of the control rats (3.9%).

Conclusion:

To our knowledge, this study is the first to evaluate a small molecular PET probe for the -amyloid deposits in vivo using micro-PET imaging in an AD-injected rat model. The suitable biological characters showed that the tracer had potential to be developed as a probe for detecting -amyloid plaques in AD.

References

1. Cai LS, Innis RB, Pike VW. Radioligand development for PET imaging of -amyloid (A)-current status. Curr Med Chem 2007; 14: 19–52. | Article | PubMed | ChemPort |
2. Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid- in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 2005; 25: 10598–606. | Article | PubMed | ChemPort |
3. Toyama H, Ye D, Ichise M, Liow JS, Cai LS, Jacobowitz D, et al. PET imaging of brain with the -amyloid probe, [¹¹C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Eur J Nucl Med Mol Imag 2005; 32: 593–600. | Article | ChemPort |
4. Cai LS, Ye D, Liow JS, Hong J, Cohen RM, Pike VW, et al. PET imaging of transgenic mice TG2576 using the beta-amyloid radioligand, [C-11]PIB. Neuroimage 2006; 31: T44–T186. | Article |
5. Shimadzu H, Suemoto T, Suzuki M, Shiomitsu T, Okamura N, Kudo Y, et al. Novel probes for imaging amyloid-: F-18 and C-11 labeling of 2-(4-aminostyryl)benzoxazole derivatives. J Label Compd Radiopharm 2004; 47: 181–90. | Article | ChemPort |
6. Zheng MQ, Yin DZ, Shen YM, Li GC. Syntheses of 2-(p-aminophenyl)-6-substituent-benzothiazoles. Chin J Organ Chem 2007; 27: 1369–73.Chinese. | ChemPort |
7. Mathis CA, Holt DP, Wang Y, Huang GF, Debnath ML, Klunk WE. F-18-labeled thioflavin-T analogs for amyloid assessment. J Nucl Med 2002; 43: p166.
8. Zheng MQ, Yin DZ, Zhang L, Cheng DF, Wang YX, Cai HC. Synthesis and evaluation of ¹⁸F-labelled PIB as amyloid imaging agents. J Label Compd Radiopharm 2007; 50 (Suppl 1): S401.
9. Cheng DF, Yin DZ, Li GC, Wang MW, Li SQ, Zheng MQ, et al. Radiolabeling and in vitro and in vivo characterization of [¹⁸F]FB-[R8,15,21,L17]-VIP as a PET imaging agent for tumor overexpressed VIP receptors. Chem Biol Drug Design 2006; 68: 319–25. | Article | ChemPort |
10. Zheng MQ, Yin DZ, Qiao JP, Zhang L, Wang YX. Syntheses and evaluation of fluorinated benzothiazole anilines as potential tracers for -amyloid plaques in Alzheimer's disease. J Fluorine Chem 2008; 129: 210–6. | Article | ChemPort |
11. Wang R, Zhang HY, Tang XC. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by -amyloid protein (1–40) in rat. Eur J Pharmacol 2001; 421: 149–56. | Article | PubMed | ChemPort |
12. Nitta A, Tuktta T, Hasegawa T, Nabeshima T. Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn J Pharmacol 1997; 73: 51–7. | Article | PubMed | ChemPort |
13. Cai HC, Yin DZ, Zhang L, Yang XF, Xu XY, Liu WG. Preparation and biological evaluation of 2-amino-6-[¹⁸F]fluoro-9-(4-hydroxy-3-hydroxy-methylbutyl) purine (6-[¹⁸F]FPCY) as a novel PET probe for imaging HSV1-tk reporter gene expression. Nucl Med Biol 2007; 34: 717–25. | Article | PubMed | ChemPort |
14. Rubins DJ, Melega WP, Lacan G, Way B, Plenevaux A, Luxen A, et al. Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain. NeuroImage 2003; 20:2100–18. | Article | PubMed |
15. Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE. Synthesis and evaluation of ¹¹C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging. Agents J Med Chem 2003; 46: 2740–54. | ChemPort |

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.